American Shared Hospital Services Director David A. Larson, M.D., PhD Wins Leksell Gamma Knife Society Pioneer Award
June 16 2016 - 8:03AM
Business Wire
AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a
leading provider of turnkey technology solutions for advanced
radiosurgical and radiation therapy services, announced today that
David A. Larson, M.D., PhD, was awarded the 2016 Leksell Gamma
Knife Society Pioneer Award. The Leksell Gamma Knife Society was
established in 1989 to provide a forum for Gamma Knife users to
share information, experiences, clinical techniques and advanced
scientific research in their quest to non-invasively treat an
expanding number of brain disorders. The Leksell Gamma Knife
Society Pioneers in Radiosurgery Award is bestowed upon researchers
who have consistently pioneered new approaches and methods that
enhance the results of Gamma Knife surgery.
AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D.,
said, "Dr. David Larson is widely recognized for seminal
contributions to radiosurgery. He was among the first to suggest
that radiosurgery alone could be adequate for the treatment of
brain metastases. He did so at a time when this concept was very
controversial, even among his own peers. His many clinical and
research contributions over the past 25 years contributed
significantly to the widespread adoption of radiosurgery, and the
Gamma Knife in particular, by the radiation oncology community.
This well-earned Pioneer Award recognizes Dr. Larson's lifetime of
accomplishments and his dramatic impact on the field of radiation
oncology."
Dr. Larson, who was elected to the AMS Board in 2011, is
professor emeritus of Radiation Oncology at the University of
California, San Francisco. Dr. Larson is also currently employed as
a radiation oncology physician at the Washington Hospital
Healthcare System Gamma Knife Program. He is an internationally
recognized authority on brain tumors and on central nervous system
and body radiosurgery, intensity modified radiotherapy, and highly
conformal radiotherapy. He holds a PhD in High Energy Physics from
the University of Chicago and an MD from the University of Miami
School of Medicine. He completed his medical internship at the
University of California, San Francisco and his radiation oncology
residency training at Harvard Medical School, where he also served
as attending physician and instructor. Dr. Larson has been a member
of the UCSF academic faculty since 1986, leading to joint
professorial appointments in the Departments of Radiation Oncology
and Neurosurgery. He has authored more than 200 scientific papers,
reviews, and book chapters. He was elected by his peers to the
presidency of numerous professional societies, including the
American Society for Radiation Oncology (ASTRO), the Northern
California Radiation Oncology Society (NCROS), and the
International Stereotactic Radiosurgery Society (ISRS). He is a
Fellow in the American College of Radiation Oncology (FACRO), the
American College of Radiology (FACR), and the American Society for
Radiology Oncology (FASTRO).
About AMS
American Shared Hospital Services provides turnkey technology
solutions for advanced radiosurgical and radiation therapy
services. AMS is the world leader in providing Gamma Knife
radiosurgery equipment, a non-invasive treatment for malignant and
benign brain tumors, vascular malformations and trigeminal
neuralgia (facial pain). The Company also offers proton therapy,
the latest IGRT and IMRT systems, as well as its proprietary
Operating Room for the 21st CenturySM concept. AMS owns a common
stock investment in Mevion Medical Systems, Inc., developer of the
compact MEVION S250 Proton Therapy System.
Safe Harbor Statement
This press release may be deemed to contain certain
forward-looking statements with respect to the financial condition,
results of operations and future plans of American Shared Hospital
Services, which involve risks and uncertainties including, but not
limited to, the risks of the Gamma Knife and radiation therapy
businesses, the risks of developing The Operating Room for the 21st
Century program, the risks of investing in Mevion Medical Systems,
Inc., and the risks of the timing, financing, and operations of the
Company’s proton therapy business. Further information on potential
factors that could affect the financial condition, results of
operations and future plans of American Shared Hospital Services is
included in the filings of the Company with the Securities and
Exchange Commission, including the Company's Annual Report on Form
10-K for the year ended December 31, 2015, its quarterly report on
Form 10-Q for the three months ended March 31, 2016, and the
definitive Proxy Statement for the Annual Meeting of Shareholders
to be held on June 21, 2016.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160616005205/en/
American Shared Hospital ServicesErnest A. Bates, M.D., (415)
788-5300Chairman and Chief Executive
Officereabates@ashs.comorBerkman AssociatesNeil Berkman, (310)
477-3118Presidentinfo@berkmanassociates.com
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024